The Filings Report

Revvity, Inc.

RVTYNYSECIK 31791Healthcare / Diagnostics & Researchfiscal year ends December69 quarters since 2009

Revenue, Q2 FY2026
$730M
+1.3% on Q2 FY2025
Net income
$52M
−3.9% on Q2 FY2025
Free cash flow
$181M
+56.7% on Q2 FY2025
Diluted EPS
$0.47
+2.2% on Q2 FY2025
Revenue, TTM
$2.9B
trailing four quarters
Net margin, TTM
8.2%
net income $238M
Free cash flow, TTM
$558M
$628M less $70M capex
Cash and equivalents
$1.0B
long-term debt $2.6B, Jul 5, 2026
Shares, 12-month change
−3.9%
112M shares, Jul 5, 2026
Buybacks, TTM
$476M
2.7% of market value
Dividends, TTM
$32M
0.2% of market value
Market value
$17.5B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 11, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended July 5, 2026, Revvity, Inc. reported revenue of $730M, +1.3% on Q2 FY2025, and net income of $52M (−3.9%). Operating margin was 12.2%. Free cash flow, operating cash flow less capital expenditures, was $181M ($192M less $11M). Diluted earnings per share were $0.47.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 11, 2026.

Revenue and net incomeRevenueNet income
$0$200M$400M$600M$800MQ3'22, Revenue: $712MQ3'22, Net income: $85MQ3'22Q4'22, Revenue: $741MQ4'22, Net income: $128MQ4'22Q1'23, Revenue: $675MQ1'23, Net income: $569MQ1'23Q2'23, Revenue: $709MQ2'23, Net income: $36MQ2'23Q3'23, Revenue: $671MQ3'23, Net income: $9MQ3'23Q4'23, Revenue: $696MQ4'23, Net income: $79MQ4'23Q1'24, Revenue: $650MQ1'24, Net income: $26MQ1'24Q2'24, Revenue: $692MQ2'24, Net income: $55MQ2'24Q3'24, Revenue: $684MQ3'24, Net income: $94MQ3'24Q4'24, Revenue: $729MQ4'24, Net income: $95MQ4'24Q1'25, Revenue: $665MQ1'25, Net income: $42MQ1'25Q2'25, Revenue: $720MQ2'25, Net income: $54MQ2'25Q3'25, Revenue: $699MQ3'25, Net income: $47MQ3'25Q4'25, Revenue: $772MQ4'25, Net income: $98MQ4'25Q1'26, Revenue: $711MQ1'26, Net income: $41MQ1'26Q2'26, Revenue: $730MQ2'26, Net income: $52MQ2'26$0$200M$400M$600M$800MQ3'22, Revenue: $712MQ3'22, Net income: $85MQ4'22, Revenue: $741MQ4'22, Net income: $128MQ4'22Q1'23, Revenue: $675MQ1'23, Net income: $569MQ2'23, Revenue: $709MQ2'23, Net income: $36MQ2'23Q3'23, Revenue: $671MQ3'23, Net income: $9MQ4'23, Revenue: $696MQ4'23, Net income: $79MQ4'23Q1'24, Revenue: $650MQ1'24, Net income: $26MQ2'24, Revenue: $692MQ2'24, Net income: $55MQ2'24Q3'24, Revenue: $684MQ3'24, Net income: $94MQ4'24, Revenue: $729MQ4'24, Net income: $95MQ4'24Q1'25, Revenue: $665MQ1'25, Net income: $42MQ2'25, Revenue: $720MQ2'25, Net income: $54MQ2'25Q3'25, Revenue: $699MQ3'25, Net income: $47MQ4'25, Revenue: $772MQ4'25, Net income: $98MQ4'25Q1'26, Revenue: $711MQ1'26, Net income: $41MQ2'26, Revenue: $730MQ2'26, Net income: $52MQ2'26

Net income losses drawn in red.

Free cash flow
−$200M−$100M$0$100M$200MQ3'22, Free cash flow: $147MQ3'22Q4'22, Free cash flow: $113MQ4'22Q1'23, Free cash flow: $43MQ1'23Q2'23, Free cash flow: −$149MQ2'23Q3'23, Free cash flow: −$56MQ3'23Q4'23, Free cash flow: $172MQ4'23Q1'24, Free cash flow: $130MQ1'24Q2'24, Free cash flow: $137MQ2'24Q3'24, Free cash flow: $126MQ3'24Q4'24, Free cash flow: $150MQ4'24Q1'25, Free cash flow: $112MQ1'25Q2'25, Free cash flow: $115MQ2'25Q3'25, Free cash flow: $120MQ3'25Q4'25, Free cash flow: $162MQ4'25Q1'26, Free cash flow: $95MQ1'26Q2'26, Free cash flow: $181MQ2'26−$200M−$100M$0$100M$200MQ3'22, Free cash flow: $147MQ4'22, Free cash flow: $113MQ4'22Q1'23, Free cash flow: $43MQ2'23, Free cash flow: −$149MQ2'23Q3'23, Free cash flow: −$56MQ4'23, Free cash flow: $172MQ4'23Q1'24, Free cash flow: $130MQ2'24, Free cash flow: $137MQ2'24Q3'24, Free cash flow: $126MQ4'24, Free cash flow: $150MQ4'24Q1'25, Free cash flow: $112MQ2'25, Free cash flow: $115MQ2'25Q3'25, Free cash flow: $120MQ4'25, Free cash flow: $162MQ4'25Q1'26, Free cash flow: $95MQ2'26, Free cash flow: $181MQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3B$4BQ3'22, Cash and equivalents: $401MQ3'22, Long-term debt: $3.9BQ3'22Q4'22, Cash and equivalents: $454MQ4'22, Long-term debt: $3.9BQ4'22Q1'23, Cash and equivalents: $2.3BQ1'23, Long-term debt: $3.9BQ1'23Q2'23, Cash and equivalents: $1.3BQ2'23, Long-term debt: $3.9BQ2'23Q3'23, Cash and equivalents: $1.1BQ3'23, Long-term debt: $3.2BQ3'23Q4'23, Cash and equivalents: $913MQ4'23, Long-term debt: $3.2BQ4'23Q1'24, Cash and equivalents: $998MQ1'24, Long-term debt: $3.2BQ1'24Q2'24, Cash and equivalents: $1.2BQ2'24, Long-term debt: $3.2BQ2'24Q3'24, Cash and equivalents: $1.2BQ3'24, Long-term debt: $3.2BQ3'24Q4'24, Cash and equivalents: $1.2BQ4'24, Long-term debt: $3.2BQ4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $3.2BQ1'25Q2'25, Cash and equivalents: $992MQ2'25, Long-term debt: $3.2BQ2'25Q3'25, Cash and equivalents: $931MQ3'25, Long-term debt: $2.6BQ3'25Q4'25, Cash and equivalents: $920MQ4'25, Long-term debt: $2.6BQ4'25Q1'26, Cash and equivalents: $860MQ1'26, Long-term debt: $2.6BQ1'26Q2'26, Cash and equivalents: $1.0BQ2'26, Long-term debt: $2.6BQ2'26$0$1B$2B$3B$4BQ3'22, Cash and equivalents: $401MQ3'22, Long-term debt: $3.9BQ4'22, Cash and equivalents: $454MQ4'22, Long-term debt: $3.9BQ4'22Q1'23, Cash and equivalents: $2.3BQ1'23, Long-term debt: $3.9BQ2'23, Cash and equivalents: $1.3BQ2'23, Long-term debt: $3.9BQ2'23Q3'23, Cash and equivalents: $1.1BQ3'23, Long-term debt: $3.2BQ4'23, Cash and equivalents: $913MQ4'23, Long-term debt: $3.2BQ4'23Q1'24, Cash and equivalents: $998MQ1'24, Long-term debt: $3.2BQ2'24, Cash and equivalents: $1.2BQ2'24, Long-term debt: $3.2BQ2'24Q3'24, Cash and equivalents: $1.2BQ3'24, Long-term debt: $3.2BQ4'24, Cash and equivalents: $1.2BQ4'24, Long-term debt: $3.2BQ4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $3.2BQ2'25, Cash and equivalents: $992MQ2'25, Long-term debt: $3.2BQ2'25Q3'25, Cash and equivalents: $931MQ3'25, Long-term debt: $2.6BQ4'25, Cash and equivalents: $920MQ4'25, Long-term debt: $2.6BQ4'25Q1'26, Cash and equivalents: $860MQ1'26, Long-term debt: $2.6BQ2'26, Cash and equivalents: $1.0BQ2'26, Long-term debt: $2.6BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 11, 2026.

Revvity, Inc. income statement, quarterly
Millions of dollarsQ2 FY2026ended Jul 5, 2026filed Aug 11, 2026Q1 FY2026ended Apr 5, 2026filed May 12, 2026Q4 FY2025ended Dec 28, 2025filed Feb 24, 2026Q3 FY2025ended Sep 28, 2025filed Nov 4, 2025Q2 FY2025ended Jun 29, 2025filed Aug 5, 2025Q1 FY2025ended Mar 30, 2025filed May 6, 2025Q4 FY2024ended Dec 29, 2024filed Feb 25, 2025Q3 FY2024ended Sep 29, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue730711772699720665729684+1.3%
Cost of revenue313323—324328289—299−4.5%
Gross profit—————————
Research and development4958585153544949−8.1%
Selling, general and administrative279254252242249250244238+12.1%
Operating income897611282917211998−1.6%
Other income (expense)(26)(26)(20)(26)(22)(20)(24)2−16.6%
Pretax income64509256695295100−7.5%
Income tax109(4)8131167−25.2%
Net income5241984754429594−3.9%
Diluted EPS ($)0.470.36—0.400.460.35—0.77+2.2%
Diluted shares (millions)112112—115118120—123—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 11, 2026.

Revvity, Inc. balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jul 5, 2026filed Aug 11, 2026Q1 FY2026ended Apr 5, 2026filed May 12, 2026Q4 FY2025ended Dec 28, 2025filed Feb 24, 2026Q3 FY2025ended Sep 28, 2025filed Nov 4, 2025Q2 FY2025ended Jun 29, 2025filed Aug 5, 2025Q1 FY2025ended Mar 30, 2025filed May 6, 2025Q4 FY2024ended Dec 29, 2024filed Feb 25, 2025Q3 FY2024ended Sep 29, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents1,0238609209319921,1381,1631,230+3.1%
Short-term investments——————00—
Total current assets2,2982,1282,2402,1442,2362,3182,3502,448+2.8%
Total assets12,04611,99712,16812,13912,36312,36112,39212,770−2.6%
Total current liabilities1,2761,2391,3311,223672648653688+90.0%
Long-term debt2,6332,6322,6312,6313,2143,1683,1503,186−18.1%
Total liabilities4,8174,8144,9184,7634,8074,7244,7264,848+0.2%
Stockholders’ equity7,2297,1837,2507,3767,5567,6377,6677,922−4.3%
Shares outstanding (millions)112112112113116118120122—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 11, 2026.

Revvity, Inc. cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jul 5, 2026filed Aug 11, 2026Q1 FY2026ended Apr 5, 2026filed May 12, 2026Q4 FY2025ended Dec 28, 2025filed Feb 24, 2026Q3 FY2025ended Sep 28, 2025filed Nov 4, 2025Q2 FY2025ended Jun 29, 2025filed Aug 5, 2025Q1 FY2025ended Mar 30, 2025filed May 6, 2025Q4 FY2024ended Dec 29, 2024filed Feb 25, 2025Q3 FY2024ended Sep 29, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow192115182139134128174148+42.9%
Capital expenditures1120201919162422−41.3%
Free cash flow (CFO − capex)18195162120115112150126+56.7%
Depreciation and amortization10210510310210397105108−0.7%
Share repurchases1686168205294154185154−94.6%
Dividends paid88888899−5.7%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 24, 2026.

Income statement

Revvity, Inc. income statement, annual
Millions of dollarsFY2025ended Dec 28, 2025filed Feb 24, 2026FY2024ended Dec 29, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Jan 1, 2023filed Mar 1, 2023FY2021ended Jan 2, 2022filed Mar 3, 2022FY2020ended Jan 3, 2021filed Mar 2, 2021FY2019ended Dec 29, 2019filed Feb 25, 2020FY2018ended Dec 30, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Jan 1, 2017filed Feb 28, 2017FY2015ended Jan 3, 2016filed Mar 1, 2016FY2014ended Dec 28, 2014filed Feb 24, 2015FY2013ended Dec 29, 2013filed Feb 25, 2014FY2012ended Dec 30, 2012filed Feb 26, 2013FY2011ended Jan 1, 2012filed Feb 28, 2012FY2010ended Jan 2, 2011filed Mar 1, 2011FY2009ended Jan 3, 2010filed Aug 10, 2010FY2008ended Dec 28, 2008filed Aug 10, 2010
Revenue2,8562,7552,7513,3123,8282,6632,8842,7782,2572,1162,1052,0702,1582,1051,9191,7021,5511,660
Cost of revenue———————1,437———————946852926
Gross profit———1,9902,4342,1101,3961,3411,0741,0139641,005976963848761——
Research and development216197217222200146189194139124113108132132116959093
Selling, general and administrative9929941,0231,026975716815812626590587648582627624487477486
Operating income3573473017431,25886736232429629525116522810391158116148
Other income (expense)(88)(31)(118)(91)(55)(67)(125)(66)1(51)(42)(41)(64)(48)(27)8(16)—
Pretax income2683161836521,2048002372582972442091241645564166100104
Income tax283331393141709201402820(6)(11)(16)63272713
Net income24127069356994372822823829323421215816770839182126
Diluted EPS ($)2.072.205.554.508.086.492.042.132.642.121.871.391.470.610.073.310.701.07
Diluted shares (millions)117123125126117112112112111110113114114115114118117—

Balance sheet

Revvity, Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 28, 2025filed Feb 24, 2026FY2024ended Dec 29, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Jan 1, 2023filed Mar 1, 2023FY2021ended Jan 2, 2022filed Mar 3, 2022FY2020ended Jan 3, 2021filed Mar 2, 2021FY2019ended Dec 29, 2019filed Feb 25, 2020FY2018ended Dec 30, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Jan 1, 2017filed Feb 28, 2017FY2015ended Jan 3, 2016filed Mar 1, 2016FY2014ended Dec 28, 2014filed Feb 24, 2015FY2013ended Dec 29, 2013filed Feb 25, 2014FY2012ended Dec 30, 2012filed Feb 26, 2013FY2011ended Jan 1, 2012filed Feb 28, 2012FY2010ended Jan 2, 2011filed Mar 1, 2011FY2009ended Jan 3, 2010filed Aug 10, 2010FY2008ended Dec 28, 2008filed Aug 10, 2010
Cash and equivalents9201,163913454603387192163202359238175175173142420180179
Short-term investments—06900——————————————
Total current assets2,2402,3503,0013,2892,4412,2391,3741,2351,2001,1901,0331,0691,0459728831,085884—
Total assets12,16812,39213,56514,13015,0017,9606,5395,9766,0914,2774,1664,1283,9473,9023,8563,2093,059—
Total current liabilities1,3316531,4501,5441,2141,652763772951603561597603581599515497—
Long-term debt2,6313,1503,1783,9234,9801,6102,0641,8771,7891,0451,0121,045932939945424558—
Total liabilities4,9184,7265,6926,7477,8594,2253,7253,3913,5882,1232,0562,0851,9521,9622,0131,2841,430—
Stockholders’ equity7,2507,6677,8737,3837,1413,7352,8142,5852,5032,1542,1102,0421,9941,9401,8421,9251,6291,569
Shares outstanding (millions)112120124126126112111111111110110113113114113113——

Cash flow statement

Revvity, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 28, 2025filed Feb 24, 2026FY2024ended Dec 29, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Jan 1, 2023filed Mar 1, 2023FY2021ended Jan 2, 2022filed Mar 3, 2022FY2020ended Jan 3, 2021filed Mar 2, 2021FY2019ended Dec 29, 2019filed Feb 25, 2020FY2018ended Dec 30, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Jan 1, 2017filed Feb 28, 2017FY2015ended Jan 3, 2016filed Mar 1, 2016FY2014ended Dec 28, 2014filed Feb 24, 2015FY2013ended Dec 29, 2013filed Feb 25, 2014FY2012ended Dec 30, 2012filed Feb 26, 2013FY2011ended Jan 1, 2012filed Feb 28, 2012FY2010ended Jan 2, 2011filed Mar 1, 2011FY2009ended Jan 3, 2010filed Aug 10, 2010FY2008ended Dec 28, 2008filed Aug 10, 2010
Operating cash flow583628916801,411892363311288351287282159152225164149218
Capital expenditures748781868664769339322827394231342635
Free cash flow (CFO − capex)509542105941,325829287218249319259254120110194131123183
Depreciation and amortization405428432427311202214181105100105110127125111898177
Share repurchases82137038981737657415276661272110731576
Dividends paid333435353231313131313232323232333333

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$1M
3 sales by 3 insiders; officers and directors $1M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$6M
17 sales by 7 insiders; officers and directors $6M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Gonzales AnitaVP and CAOopen-market sale10b5-184$155.48$13K7,117Oct 2, 2026
Sep 21, 2026Krakowiak MaxwellPlease See Remarksopen-market sale10b5-11,631$144.53$236K14,781Sep 23, 2026
Sep 16, 2026Vohra Tajinder SPlease See Remarksopen-market sale10b5-17,330$140.88$1M6,635Sep 18, 2026
Aug 25, 2026Michas Alexis PDirectorgiftindirect285$0.00—6,985Aug 25, 2026
Aug 14, 2026Goldberg Joel SPlease See Remarksgift27,785$0.00—13,729Aug 18, 2026
Aug 14, 2026Goldberg Joel SPlease See Remarksgiftindirect27,785$0.00—91,494Aug 18, 2026
Aug 13, 2026Singh Prahlad R.Please See Remarks, Directorgift7,636$0.00—105,676Aug 17, 2026
Aug 13, 2026Singh Prahlad R.Please See Remarks, Directorgiftindirect7,636$0.00—54,219Aug 17, 2026
Aug 13, 2026Singh Prahlad R.Please See Remarks, Directorgift59,650$0.00—46,026Aug 17, 2026
Aug 13, 2026Singh Prahlad R.Please See Remarks, Directorgiftindirect59,650$0.00—59,650Aug 17, 2026
Jul 20, 2026Gonzales AnitaVice President and CAOopen-market sale10b5-185$109.48$9K7,201Jul 22, 2026
Jun 15, 2026Gonzales AnitaVice President and CAOtax withholding33$99.66$3K7,286Jun 17, 2026
May 7, 2026Michas Alexis PDirectoraward1,217$0.00—62,300May 11, 2026
May 7, 2026Michas Alexis PDirectoraward1,467$0.00—63,767May 11, 2026
May 7, 2026Vandebroek Sophie V.Directoraward1,015$0.00—6,103May 11, 2026
May 7, 2026Vandebroek Sophie V.Directoraward1,265$0.00—7,368May 11, 2026
May 7, 2026Klobuchar Michael ADirectoraward1,015$0.00—6,103May 11, 2026
May 7, 2026Klobuchar Michael ADirectoraward1,265$0.00—7,368May 11, 2026
May 7, 2026Witney FrankDirectoraward1,015$0.00—22,089May 11, 2026
May 7, 2026Witney FrankDirectoraward1,265$0.00—23,354May 11, 2026
May 7, 2026Chapin Samuel R.Directoraward1,015$0.00—21,411May 11, 2026
May 7, 2026Chapin Samuel R.Directoraward1,265$0.00—22,676May 11, 2026
May 7, 2026Vounatsos MichelDirectoraward1,015$0.00—12,712May 11, 2026
May 7, 2026Vounatsos MichelDirectoraward1,265$0.00—13,977May 11, 2026
May 7, 2026McMurry-Heath MichelleDirectoraward1,015$0.00—5,248May 11, 2026

Full insider history for Revvity, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
REVVITY, INC, CIK 31791 on EDGAR
Extract generated
November 1, 2026
Withheld
9 line-years whose four quarters do not sum to the filed year: operating income FY2014, pretax income FY2014, revenue FY2014, operating income FY2016, operating income FY2020, pretax income FY2020, revenue FY2020, opex sga FY2021, rnd FY2021
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2023
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold, CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 1, 2026.

JSON file
/data/financials/RVTY.json